AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

799.528

+4.4020.55%

Number of Gainers:16

Number of Losers:5

Number of Flat:24

PE:- -

High:801.011

Open:795.126

Low:789.417

Close:795.126

Loading ...

3 oversold ASX shares begging to rebound

NewMarket Greenlights $100 Million AMPAC Expansion; Maintains Dividend

MT Newswires Live

ASX Penny Stocks To Watch In April 2025

Simply Wall St.

Warren Buffett's warning to markets played out perfectly: the time to be greedy may be approaching

ASX Growth Companies With Strong Insider Backing In April 2025

Simply Wall St.

West Pharmaceutical CFO Bernard Birkett to Retire

MT Newswires Live

Cynata Therapeutics to Act as Core Partner in Australian Regenerative Therapy Manufacturing Initiative; Shares Up 3%

MT Newswires Live

What would Warren Buffett do with ASX shares right now?

Imricor Commences VISABL-VT Trial

Exploring 3 Undervalued Small Caps With Insider Buying In Global Markets

Simply Wall St.

Monash IVF Says Brisbane Clinic Incident Not Expected to Impact Share Price; Shares Rise 7%

MT Newswires Live

Monash IVF Group Ltd - Response to ASX Aware Letter

THOMSON REUTERS

Monash IVF Group Ltd - Incident Is Expected to Fall Within Scope of Mvf's Insurance.

THOMSON REUTERS

Monash IVF Group Ltd - Considers That Incident Is an Isolated Incidence of Human Error

THOMSON REUTERS

Why Orthocell, Paladin Energy, Telix, and Woodside shares are racing higher today

BRIEF-Orthocell Says First U.S. Distributors Signed For Remplirs

Guess which ASX All Ords stock is up 10% on big news

Orthocell Appoints First US Distributors for Nerve Repair Product; Shares Rise 6%

MT Newswires Live

BUZZ-Australia's Orthocell rises as co secures US distributors for flagship product

Orthocell - First US Distributors Signed for Remplirs

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":799.52814,"timestamp":1745474399881,"preClose":795.126,"halted":0,"volume":54911678,"delay":0,"changeRate":0.005536,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.402161,"latestTime":"04-24 16:00:00 AEST","open":795.126,"high":801.01086,"low":789.4166,"amount":126091203,"amplitude":0.014582,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745798400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745452800000,1745474400000]],"turnoverRate":0.001533,"increases":18,"decrements":5,"flats":20,"marketCap":126444366382.875,"floatMarketCap":123750989381},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":801.01086,"amplitude":0.014582,"preClose":795.126,"low":789.4166,"latestPrice":799.52814,"volume":54911678,"delay":0,"open":795.126,"prevYearClose":936.801,"prevWeekClose":793.051,"prevMonthClose":815.605,"prevQuarterClose":815.605,"fiveDayClose":805.476,"twentyDayClose":842.87,"sixtyDayClose":909.271,"secType":"PLATE","market":"AU","turnoverRate":0.001533,"marketCap":126444366382.875,"floatMarketCap":123750989381,"timestamp":1745474399881,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":16,"down":5,"flat":24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530919288","title":"3 oversold ASX shares begging to rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2530919288","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530919288?lang=en_us&edition=fundamental","pubTime":"2025-04-26 06:35","pubTimestamp":1745620500,"startTime":"0","endTime":"0","summary":"The market has been serving up a fair amount of volatility lately, and in the rush to de-risk portfolios, even some of the highest quality ASX shares have been dragged lower. But as history often show","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/26/3-oversold-asx-shares-begging-to-rebound/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1791807156.HKD","LU1868836757.USD","LU1868837300.USD","WTC.AU","IE00BSNM7G36.USD","LU2471134879.HKD","IE00B19Z3B42.SGD","LU2237443895.HKD","BK7501","LU1868837136.USD","LU0061475181.USD","LU2471134796.USD","BK4550","IE0002270589.USD","LU2237438978.USD","LU2237443549.SGD","LU0251131958.USD","LU2750360997.AUD","CSL.AU","LU2237443465.HKD","LU1868836591.USD","LU2471134952.CNY","BK4516","BK4585","LU0742534661.SGD","BK7016","BK7067","LU2237443622.USD","BK4504","LU1868836914.USD","BK4552","BK7094","IE0004091025.USD","IE0034235188.USD","BK7511","LU0251142724.SGD","LU0106831901.USD","LU1668664300.SGD","LU2750360641.GBP","LU2237443978.SGD","LU2237443382.USD","BK7503","BK7508","IE00BFXG1179.USD","LU2471134523.USD","BK4588","BK4127","IE0004086264.USD","LU0096364046.USD","PME.AU"],"gpt_icon":0},{"id":"2530708169","title":"NewMarket Greenlights $100 Million AMPAC Expansion; Maintains Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2530708169","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530708169?lang=en_us&edition=fundamental","pubTime":"2025-04-25 16:47","pubTimestamp":1745570838,"startTime":"0","endTime":"0","summary":"NewMarket Corp.  said Thursday it has approved up to $100 million in capital spending by its AMPAC unit to boost ammonium perchlorate production, a critical component in solid rocket motors.The expansion will include a new production line, increasing AMPAC's manufacturing capacity by more than 50%, the company said.NewMarket expects the project to be completed in 2026 and noted that it will enhance supply chain resilience.The company also maintained a quarterly dividend of $2.75 per share, payable July 1 to shareholders of record as of June 16.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NEU.AU","NEU","BK7096","BK4109","BK7508"],"gpt_icon":0},{"id":"2530940029","title":"ASX Penny Stocks To Watch In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530940029","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530940029?lang=en_us&edition=fundamental","pubTime":"2025-04-25 11:05","pubTimestamp":1745550311,"startTime":"0","endTime":"0","summary":"The Australian market has shown resilience, with the ASX200 bouncing back to pre-tariff levels despite looming US tariffs on key sectors such as copper and pharmaceuticals. In this climate of cautious optimism, investors might find opportunities in penny stocks—companies that are smaller or newer but can offer substantial growth potential at lower price points. While the term \"penny stocks\" may seem dated, these investments continue to hold promise when supported by strong financials and robust fundamentals.Overview: Macmahon Holdings Limited offers surface and underground mining, mining support, and civil infrastructure services to mining companies in Australia and Southeast Asia, with a market cap of A$580.66 million.Operations: The company generates revenue from providing surface and underground mining, mining support, and civil infrastructure services across Australia and Southeast Asia.ASX:MAH Debt to Equity History and Analysis as at Apr 2025. Overview: Race Oncology Limited is a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-penny-stocks-watch-april-030511339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7045","BK7129","BK7058","EZZ.AU","LBL.AU","SHA.AU","BK7067","BIS.AU","IGL.AU","BK7095","XAO.AU","GTN.AU","SXE.AU","XJO.AU","RAC.AU","NWH.AU","MAH.AU","CLX.AU","RPL.AU","NGI.AU","XKO.AU","BK7055","BK7048","BK7088","BK7062","BK7508"],"gpt_icon":0},{"id":"2530547992","title":"Warren Buffett's warning to markets played out perfectly: the time to be greedy may be approaching","url":"https://stock-news.laohu8.com/highlight/detail?id=2530547992","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530547992?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:33","pubTimestamp":1745526780,"startTime":"0","endTime":"0","summary":"For long-term investors, periods of volatility often mark the beginning—not the end—of a wealth-building opportunity. Many quality ASX shares, from stalwarts like biotech giant CSL Ltd  and investment bank Macquarie Group Ltd  to fast-growing disruptors like health imaging technology company Pro Medicus Ltd  and online furniture and homewares retailer Temple & Webster Group Ltd , are trading at sharp discounts to what investors were willing to pay just a matter of weeks ago. If you have ve been sitting on the sidelines, waiting for the perfect moment—this may be it. Not because anyone can pick a bottom, but because, as Buffett shows time and again, value appears when investors are being fearful. So, is it time to be greedy?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/25/warren-buffetts-warning-to-markets-played-out-perfectly-the-time-to-be-greedy-may-be-approaching/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0149725797.USD","LU0154236417.USD","BK4176","LU0251142724.SGD","IE000M9KFDE8.USD","LU1363072403.SGD","MQG.AU","TPW.AU","BK4534","LU0256863811.USD","LU0640476718.USD","BK4550","IE00BJLML261.HKD","IE00BWXC8680.SGD","IE00B3S45H60.SGD","LU0742534661.SGD","LU0417517546.SGD","LU1074936037.SGD","BK4588","BK4585","LU0048573561.USD","BK7046","LU0980610538.SGD","LU0130102774.USD","LU1366333091.USD","BK4581","IE0034235303.USD","LU0234570918.USD","BRK.B","BK7508","IE00BKDWB100.SGD","BK7094","LU0251131958.USD","BK4533","BK7501","LU0648001328.SGD","LU1571399168.USD","CSL.AU","BK7511","LU0971096721.USD","LU0053666078.USD","LU0683600562.USD","IE00BK4W5L77.USD","LU0234572021.USD","IE00BK4W5M84.HKD","PME.AU","IE00B1XK9C88.USD","BK7049","IE00B775SV38.USD","LU0787776722.HKD"],"gpt_icon":1},{"id":"2530296775","title":"ASX Growth Companies With Strong Insider Backing In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530296775","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530296775?lang=en_us&edition=fundamental","pubTime":"2025-04-25 03:38","pubTimestamp":1745523499,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a turbulent landscape marked by recent US tariffs on key sectors and fluctuating indices, investors are increasingly focused on identifying resilient growth opportunities. In this context, companies with substantial insider ownership can offer a compelling proposition, as they often signal confidence in long-term potential and alignment with shareholder interests.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 94 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Aussie Broadband is poised for significant earnings growth, projected at 27.6% annually, outpacing the Australian market. Despite a low forecasted return on equity of 10.8%, the company plans to expand through organic growth and mergers and acquisitions, as stated in their recent investor day. Recent board changes include Graeme Barclay joining as a Non-Executive Director, bringing extensive telecommunications e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-strong-insider-193819249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7129","BK7095","BK7015","BK7077","BK7508","XKO.AU","BK7070","BK7093","AAL.AU","BK7036","PLT.AU","BK7096","ABB.AU","XAO.AU","BK7021","NWF.AU","BBT.AU","CYC.AU","TTT.AU","ACR.AU","BK7007","XJO.AU","IMA.AU","UNI.AU","BK7116","FLT.AU","BK7084","AVA.AU","BK7078","FEX.AU"],"gpt_icon":0},{"id":"2529705932","title":"West Pharmaceutical CFO Bernard Birkett to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2529705932","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529705932?lang=en_us&edition=fundamental","pubTime":"2025-04-24 22:18","pubTimestamp":1745504339,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services  said Thursday that Chief Financial Officer Bernard Birkett plans to retire later this year and that a search for his successor is underway.Birkett is expected to remain in the CFO role until a successor is appointed and will then serve as an advisor to support a smooth transition, the company said.West also said it appointed Shane Campbell as chief proprietary segment officer, starting May 5. Campbell most recently served as chief commercial officer of the construction materials business at Carlisle .Shares of West Pharmaceutical Services were down 3.5% in recent trading.Price: 210.50, Change: -7.68, Percent Change: -3.52","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ23171101.USD","SG9999004303.SGD","IE00B64QTZ34.USD","BK4121","BK4585","IE00BYQQ9H92.USD","CSL.AU","LU1169589451.USD","BK4588","BK7511","CSL","BK7508","BK7067","WST","BK4086","BK4567","LU0728928796.USD","LU1169590202.USD","IE00BFXG0V08.USD","BK7501","BK4504"],"gpt_icon":0},{"id":"2529617985","title":"Cynata Therapeutics to Act as Core Partner in Australian Regenerative Therapy Manufacturing Initiative; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529617985","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529617985?lang=en_us&edition=fundamental","pubTime":"2025-04-24 11:47","pubTimestamp":1745466456,"startTime":"0","endTime":"0","summary":"Cynata Therapeutics  said it will act as a core partner in the Solutions for Manufacturing Advanced Regenerative Therapies Cooperative Research Center , which recently received Australian Government funding, according to a Thursday filing with the Australian bourse.SMART CRC is a AU$238 million national initiative with over 60 industry, government, healthcare, universities, and research institute partners, the filing said.The partners will now move to draft and execute formal agreements, per the filing.Shares were up 3% in afternoon trade on Thursday.Price : $0.20, Change: $+0.0050, Percent Change: +2.63%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7508","BK7067","XKO.AU","LENZ","BK4139","XAO.AU","BK4007","CYP.AU","XJO.AU"],"gpt_icon":0},{"id":"2529569525","title":"What would Warren Buffett do with ASX shares right now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529569525","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529569525?lang=en_us&edition=fundamental","pubTime":"2025-04-24 06:39","pubTimestamp":1745447963,"startTime":"0","endTime":"0","summary":"It is fair to say that there's been no shortage of fear on the market lately. Trade tensions, volatility, and headlines predicting the next recession have sent many investors running for the sidelines. But if there's one person who would see today's environment as ripe with opportunity, it is Warren Buffett. While the Oracle of Omaha doesn't typically invest in the ASX, his investment playbook is universal — and it is perfectly suited to moments like these. So, if Buffett were eyeing the ASX today, what might he do?He probably wouldn't even notice. His holding periods often span 20–30 years, and his performance has been built on patience, not prediction. That's a good reminder for any ASX investor. Foolish takeaway Warren Buffett may not be browsing the ASX boards, but his principles can still guide you through turbulent times. Buy quality, ignore the noise, and think long term. In fact, Buffett said it best when he said:  Opportunities come infrequently. When it rains gold, put out th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/24/what-would-warren-buffett-do-with-asx-shares-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00BK4W5M84.HKD","LU0234570918.USD","LU0256863811.USD","LU1914381329.SGD","BK4534","BK7508","LU0048573561.USD","LOV.AU","BK7511","LU0980610538.SGD","IE00B1XK9C88.USD","BK7016","LU0154236417.USD","IE00BWXC8680.SGD","LU0053666078.USD","LU0742534661.SGD","LU0130102774.USD","BK4585","IE00B775SV38.USD","LU1280957306.USD","LU1363072403.SGD","LU1074936037.SGD","LU0640476718.USD","BK4550","IE000M9KFDE8.USD","IE00B3S45H60.SGD","LU0971096721.USD","LU0251131958.USD","RMD.AU","IE00BKDWB100.SGD","BK4581","LU0787776722.HKD","BK7503","TNE.AU","CSL.AU","BK7501","LU1571399168.USD","IE00BK4W5L77.USD","IE00BJLML261.HKD","BK4588","BK7128","LU0149725797.USD","BK4533","LU0683600562.USD","LU0170899867.USD","LU0417517546.SGD","IE0034235303.USD","BRK.B","LU0648001328.SGD","BK7067"],"gpt_icon":1},{"id":"2529504436","title":"Imricor Commences VISABL-VT Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2529504436","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529504436?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:55","pubTimestamp":1745409300,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, April 23, 2025----Imricor Medical Systems, Inc.   is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI with the Company’s NorthStar Mapping System. The procedure was performed by the team at the Amsterdam University Medical Centre , ranked in 2025 by Newsweek as the best hospital in The Netherlands, and in the top 35 worldwide.The procedure marked several world firsts. It was the first ventricular ablation to be guided by real-time MRI, and it was the first left-sided ablation to be performed under real-time MRI guidance. The patient was treated for right-sided and left-sided premature ventricular complexes .Imricor’s Chair and CEO, Steve Wedan, commented, \"We formed Imricor in 2006 with the goal of delivering MRI-compatible catheters and systems that would enable real-time MRI guidance of complex ventricular and atrial ablation procedures, where the power of MRI has the pote","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imricor-commences-visabl-vt-trial-115500347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IMR.AU","BK4585","BK7508","BK4168","BK7503","BK7007","AUMC","VT","BK4588"],"gpt_icon":0},{"id":"2529504579","title":"Exploring 3 Undervalued Small Caps With Insider Buying In Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2529504579","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529504579?lang=en_us&edition=fundamental","pubTime":"2025-04-23 17:39","pubTimestamp":1745401172,"startTime":"0","endTime":"0","summary":"In recent weeks, global markets have experienced mixed performance, with smaller-cap indexes like the S&P MidCap 400 and Russell 2000 showing gains despite broader market challenges. Economic uncertainty, particularly around trade policies and interest rates, continues to influence investor sentiment across various sectors. In this environment, identifying promising small-cap stocks involves looking for those with strong fundamentals and positive insider activity that may offer potential opportunities amid volatility.Click here to see the full list of 154 stocks from our Undervalued Global Small Caps With Insider Buying screener.Cedar Woods Properties, a smaller company in its sector, shows potential for value with recent insider confidence as William Hames acquired 16,000 shares valued at approximately A$71,200. Despite relying on external borrowing for funding and having a high debt level, the company reported significant growth in sales and net income for the half-year ending Decemb","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-3-undervalued-small-caps-093932082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7508","NEU.AU","BK7145","HIE","BK7096","CWP.AU"],"gpt_icon":0},{"id":"2529481575","title":"Monash IVF Says Brisbane Clinic Incident Not Expected to Impact Share Price; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529481575","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529481575?lang=en_us&edition=fundamental","pubTime":"2025-04-23 13:17","pubTimestamp":1745385431,"startTime":"0","endTime":"0","summary":"Monash IVF Group  said that the incident at its Brisbane clinic, where an embryo was mistakenly implanted into the wrong patient, resulting in the birth of a child, will not have a material impact on share price, according to a response to an ASX Aware letter filed on Wednesday.The company said in response to a letter from the ASX that the incident is an isolated incident of human error.MVF confirmed that an internal investigation is ongoing.Shares of the company rose 7% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MVF.AU","BK7113","BK7508"],"gpt_icon":0},{"id":"2529517946","title":"Monash IVF Group Ltd - Response to ASX Aware Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2529517946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529517946?lang=en_us&edition=fundamental","pubTime":"2025-04-23 12:34","pubTimestamp":1745382876,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R02L2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVF.AU","BK7113","BK7508"],"gpt_icon":0},{"id":"2529517945","title":"Monash IVF Group Ltd - Incident Is Expected to Fall Within Scope of Mvf's Insurance.","url":"https://stock-news.laohu8.com/highlight/detail?id=2529517945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529517945?lang=en_us&edition=fundamental","pubTime":"2025-04-23 12:34","pubTimestamp":1745382876,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R02L2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MVF.AU","BK7113"],"gpt_icon":0},{"id":"2529351794","title":"Monash IVF Group Ltd - Considers That Incident Is an Isolated Incidence of Human Error","url":"https://stock-news.laohu8.com/highlight/detail?id=2529351794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529351794?lang=en_us&edition=fundamental","pubTime":"2025-04-23 12:34","pubTimestamp":1745382876,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R02L2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7113","BK7508","MVF.AU"],"gpt_icon":0},{"id":"2529290519","title":"Why Orthocell, Paladin Energy, Telix, and Woodside shares are racing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2529290519","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529290519?lang=en_us&edition=fundamental","pubTime":"2025-04-23 10:39","pubTimestamp":1745375981,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on course to record a strong gain. At the time of writing, the benchmark index is up 1.6% to 7,942.8 points. Four ASX shares that are rising more","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/23/why-orthocell-paladin-energy-telix-and-woodside-shares-are-racing-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","BK7083","PDN.AU","OCC.AU","XJO.AU","BK7142","WDS.AU","TLX.AU","BK7145","BK7508","BK1258","BK7509","00495","LHM.AU","BK1229"],"gpt_icon":0},{"id":"2529945645","title":"BRIEF-Orthocell Says First U.S. Distributors Signed For Remplirs","url":"https://stock-news.laohu8.com/highlight/detail?id=2529945645","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529945645?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:36","pubTimestamp":1745372186,"startTime":"0","endTime":"0","summary":"BRIEF-Orthocell Says First U.S. Distributors Signed For RemplirsApril 23 (Reuters) - Orthocell Ltd OCC.AX:FIRST US DISTRIBUTORS SIGNED FOR REMPLIRSFurther company coverage: OCC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R02KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCC.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2529551924","title":"Guess which ASX All Ords stock is up 10% on big news","url":"https://stock-news.laohu8.com/highlight/detail?id=2529551924","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529551924?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:24","pubTimestamp":1745371481,"startTime":"0","endTime":"0","summary":"It has been another good day for owners of Orthocell Ltd  shares. In morning trade, the ASX All Ords stock is up 10% to $1.29. This means that the regenerative medicine company's shares are now up 240% over the past 12 months. Why is this ASX All Ords stock racing higher?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/23/guess-which-asx-all-ords-stock-is-up-10-on-big-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","OCC.AU","BK7067"],"gpt_icon":0},{"id":"2529796599","title":"Orthocell Appoints First US Distributors for Nerve Repair Product; Shares Rise 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529796599","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529796599?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:17","pubTimestamp":1745371028,"startTime":"0","endTime":"0","summary":"Orthocell (ASX:OCC) has appointed its first four US distributors operating in Michigan, Virginia, Colorado, and Indiana, for its nerve repair device Remplir, according to a Wednesday filing with the A","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XKO.AU","OCC.AU","BK7067","XAO.AU","BK7508"],"gpt_icon":0},{"id":"2529599398","title":"BUZZ-Australia's Orthocell rises as co secures US distributors for flagship product","url":"https://stock-news.laohu8.com/highlight/detail?id=2529599398","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529599398?lang=en_us&edition=fundamental","pubTime":"2025-04-23 09:04","pubTimestamp":1745370269,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Orthocell rises as co secures US distributors for flagship product** Shares of Orthocell OCC.AX rise 8.1% to A$1.27, snap a four-day losing streak ** Stock set for its strongest sessi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nL4N3R1037:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","OCC.AU"],"gpt_icon":0},{"id":"2529567258","title":"Orthocell - First US Distributors Signed for Remplirs","url":"https://stock-news.laohu8.com/highlight/detail?id=2529567258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529567258?lang=en_us&edition=fundamental","pubTime":"2025-04-23 07:42","pubTimestamp":1745365343,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R02KL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCC.AU","BK7508","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":97,"code":"91000000","status":"200"}]}}